New drug trial offers hope for stiff, painful back condition
NCT ID NCT07237568
Summary
This study is testing an investigational drug called LNK01001 for adults with active ankylosing spondylitis, a condition causing back pain and stiffness. For 16 weeks, about 350 participants will receive either the drug or a placebo pill twice daily to see if LNK01001 is better at reducing symptoms and improving daily function. The main goal is to see if more people taking the drug achieve significant relief in pain, stiffness, and physical ability compared to those taking the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.